Status:
COMPLETED
Cord Blood Stem Cell Transplantation Study (COBLT)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Anemia, Aplastic
Fanconi Anemia
Eligibility:
All Genders
Up to 55 years
Phase:
PHASE2
Brief Summary
To evaluate if HLA-mismatched, unrelated-donor umbilical cord blood stem and progenitor cell units (UCBU) offered a clinically acceptable alternative to matched unrelated-donor allogeneic bone marrow ...
Detailed Description
BACKGROUND: Bone marrow transplantation is an effective therapy for a variety of genetic and hematologic disorders. Donated bone marrow, which provides a source of stem and progenitor cells for bone ...
Eligibility Criteria
Mothers of Infant-donors must complete a medical history form, have an uncomplicated delivery, and deliver at UCLA or Duke.
Patients are those who need a transplant but don't have a matched marrow donor or can't wait to find one.
Key Trial Info
Start Date :
September 1 1996
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000603
Start Date
September 1 1996
End Date
October 1 2007
Last Update
April 14 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.